These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14403724)

  • 21. Salmonella typhi Vi antigen-negative isolates in India and prophylactic typhoid immunization.
    Arya SC
    Natl Med J India; 2000; 13(4):220. PubMed ID: 11002694
    [No Abstract]   [Full Text] [Related]  

  • 22. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Schwartz E
    N Engl J Med; 2009 Nov; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Production of mucus in the typhoid-paratyphoid-coli group as a mutation phenomenon].
    RAETTIG H
    Zentralbl Bakteriol Orig; 1951 Aug; 157(1-2):62-5. PubMed ID: 14884664
    [No Abstract]   [Full Text] [Related]  

  • 25. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Report on a new smooth Vi-free and non-flagellated typhoid strain; O-125].
    ROSCHKA R
    Z Hyg Infektionskr; 1953; 136(4):400-4. PubMed ID: 13103298
    [No Abstract]   [Full Text] [Related]  

  • 27. [VIRULENCE OF LEVOMYCETIN-RESISTANT TYPHO-PARATYPHOID BACTERIA ISOLATED FROM TYPHOID PATIENTS AND CARRIERS FOLLOWING LEVOMYCETIN THERAPY].
    GNETNEV AM
    Antibiotiki; 1964 Aug; 9():750-3. PubMed ID: 14239569
    [No Abstract]   [Full Text] [Related]  

  • 28. [Typhoid and paratyphoid fevers].
    ROZENFEL'D PE
    Med Sestra; 1955 Jun; (6):10-5. PubMed ID: 14393376
    [No Abstract]   [Full Text] [Related]  

  • 29. IMMUNE REACTIONS IN HUMAN BEINGS VACCINATED WITH TYPHOID O, VI AND O+VI+H VACCINES, WITH SPECIAL REFERENCES TO THE SPECIFIC BACTERICIDAL ACTIVITY OF THE SERUM.
    KAROLCEK J; RUSINKO M; DRASKOVICOVA M; ODLER I; BATOROVA L
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():177-89. PubMed ID: 14184873
    [No Abstract]   [Full Text] [Related]  

  • 30. [Type determination of typhoid and paratyphoid B bacteria by bacteriophage].
    BRANDIS H; IMAMURA PS
    Jpn J Exp Med; 1955 Jun; 25(3):85-91. PubMed ID: 13318774
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complementary lysotyping of typhoid lysotypes F 1 and F 4 by means of a new Vi phage].
    CHOMICZEWSKI J
    Zentralbl Bakteriol; 1961 Mar; 181():388-90. PubMed ID: 14448700
    [No Abstract]   [Full Text] [Related]  

  • 32. Should close contacts of returning travellers with typhoid fever be protected by vaccination?
    Kantele A
    Vaccine; 2015 Mar; 33(12):1419-21. PubMed ID: 25678244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of phage typing of typhoid and paratyphoid B bacteria in epidemiology].
    NICOLLE P
    Rev Hyg Med Soc; 1953; 1(2):194-8. PubMed ID: 13075245
    [No Abstract]   [Full Text] [Related]  

  • 34. [Determination of typhoid germs in the water].
    THIELE H; BRINKMANN E
    Z Hyg Infektionskr; 1953; 137(4):374-98. PubMed ID: 13137220
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental transformation of the typhoid bacillus in to paratyphoid B bacillus].
    HERRMANN W
    Z Hyg Infektionskr; 1950; 130(5):485-9. PubMed ID: 15431835
    [No Abstract]   [Full Text] [Related]  

  • 36. [Typhoid and salmonellosis in infants].
    TACCONE G
    Pediatria (Napoli); 1950; 58(5-6):310-24. PubMed ID: 15440223
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bismuth sulfite agar as a typhoid-paratyphoid culture medium].
    SCHLIRF K; SEIDENSTUCKER H
    Zentralbl Bakteriol Orig; 1951 Oct; 157(5):356-69. PubMed ID: 14914087
    [No Abstract]   [Full Text] [Related]  

  • 38. [Problem of elimination of typhoid and paratyphoid bacteria in stool].
    KATHE J
    Z Arztl Fortbild (Jena); 1956 Mar; 50(6):249-58. PubMed ID: 13338340
    [No Abstract]   [Full Text] [Related]  

  • 39. [Significance of Vi-agglutination in the detection of typhoid carriers].
    WILDFUHR G
    Z Gesamte Inn Med; 1951 Mar; 6(5-6):158-60. PubMed ID: 14836908
    [No Abstract]   [Full Text] [Related]  

  • 40. [TREATMENT OF PATIENTS WITH TYPHOID FEVER WITH A CHEMICAL PREPARATION OF VI-ANTIGEN OF S. TYPHI COMBINED WITH PROLONGED CONTINUOUS ADMINISTRATION OF ANTIBIOTICS].
    STARSHINOVA VS; LEVENSON VI
    Sov Med; 1964 Dec; 27():42-7. PubMed ID: 14323961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.